Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH).
Valgimigli M, van Mieghem CA, Ong AT, Aoki J, Granillo GA, McFadden EP, Kappetein AP, de Feyter PJ, Smits PC, Regar E, Van der Giessen WJ, Sianos G, de Jaegere P, Van Domburg RT, Serruys PW. Valgimigli M, et al. Among authors: sianos g. Circulation. 2005 Mar 22;111(11):1383-9. doi: 10.1161/01.CIR.0000158486.20865.8B. Circulation. 2005. PMID: 15781749
High shear stress after successful balloon angioplasty is associated with restenosis and target lesion revascularization.
Thury A, van Langenhove G, Carlier SG, Albertal M, Kozuma K, Regar E, Sianos G, Wentzel JJ, Krams R, Slager CJ, Piek JJ, Serruys PW; DEBATE Investigators. Doppler Endpoints Balloon Angioplasty Trial Europe. Thury A, et al. Among authors: sianos g. Am Heart J. 2002 Jul;144(1):136-43. doi: 10.1067/mhj.2002.123110. Am Heart J. 2002. PMID: 12094200
Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease.
Arampatzis CA, Lemos PA, Tanabe K, Hoye A, Degertekin M, Saia F, Lee CH, Ruiter A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feijter P, van Domburg R, Serruys PW. Arampatzis CA, et al. Among authors: sianos g. Am J Cardiol. 2003 Aug 1;92(3):327-9. doi: 10.1016/s0002-9149(03)00640-4. Am J Cardiol. 2003. PMID: 12888147 Clinical Trial.
Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance.
Agostoni P, Valgimigli M, Van Mieghem CA, Rodriguez-Granillo GA, Aoki J, Ong AT, Tsuchida K, McFadden EP, Ligthart JM, Smits PC, de Jaegere P, Sianos G, Van der Giessen WJ, De Feyter P, Serruys PW. Agostoni P, et al. Among authors: sianos g. Am J Cardiol. 2005 Mar 1;95(5):644-7. doi: 10.1016/j.amjcard.2004.10.042. Am J Cardiol. 2005. PMID: 15721110
Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis.
Valgimigli M, Malagutti P, Aoki J, Garcia-Garcia HM, Rodriguez Granillo GA, van Mieghem CA, Ligthart JM, Ong AT, Sianos G, Regar E, Van Domburg RT, De Feyter P, de Jaegere P, Serruys PW. Valgimigli M, et al. Among authors: sianos g. J Am Coll Cardiol. 2006 Feb 7;47(3):507-14. doi: 10.1016/j.jacc.2005.09.040. Epub 2006 Jan 18. J Am Coll Cardiol. 2006. PMID: 16458128 Free article.
Persistence of neointimal growth 12 months after intervention and occurrence of delayed restenosis in patients with left main coronary artery disease treated with drug-eluting stents.
Valgimigli M, Malagutti P, van Mieghem CA, Vaina S, Ligthart JM, Sianos G, Serruys PW. Valgimigli M, et al. Among authors: sianos g. J Am Coll Cardiol. 2006 Apr 4;47(7):1491-4. doi: 10.1016/j.jacc.2006.01.008. Epub 2006 Mar 15. J Am Coll Cardiol. 2006. PMID: 16580544 Free article. No abstract available.
246 results